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Summary
 
The positive selection of CD4
 
1
 
 T cells requires the expression of major histocompatibility
complex (MHC) class II molecules in the thymus, but the role of self-peptides complexed to
class II molecules is still a matter of debate. Recently, it was observed that transgenic mice ex-
pressing a single peptide–MHC class II complex positively select significant numbers of diverse
CD4
 
1
 
 T cells in the thymus. However, the number of selected T cell specificities has not been
evaluated so far. Here, we have sequenced 700 junctional complementarity determining re-
gions 3 (CDR3) from T cell receptors (TCRs) carrying V
 
b
 
11-J
 
b
 
1.1 or V
 
b
 
12-J
 
b
 
1.1 rearrange-
ments. We found that a single peptide–MHC class II complex positively selects at least 10
 
5
 
 dif-
ferent V
 
b
 
 rearrangements. Our data yield a first evaluation of the size of the T cell repertoire.
In addition, they provide evidence that the single E
 
a
 
52-68–I-A
 
b
 
 complex skews the amino
acid frequency in the TCR CDR3 loop of positively selected T cells. A detailed analysis of
CDR3 sequences indicates that a fraction of the 
 
b
 
 chain repertoire bears the imprint of the se-
lecting self-peptide.
Key words: thymus • major histocompatibility complex • T cell receptors •
repertoire development • transgenic/knockout
 
D
 
uring development, thymocytes undergo two steps of
selection, each involving interaction with self-MHC
molecules (1–4). Positive selection rescues thymocytes
from programmed cell death and ensures that the mature T
cell repertoire is directed against foreign peptides bound to
self-MHC molecules (5–8). Subsequently, negative selec-
tion eliminates, through clonal deletion, T cells with po-
tentially autoreactive receptors (1, 2, 9, 10).
Using in vitro fetal thymic organ culture system from 
 
b
 
2
microglobulin- or transporters associated with antigen pro-
cessing (TAP)-deficient mice, it was shown that peptides
were important for positive selection of CD8
 
1
 
 T cells (11,
12). Similar experiments with mice expressing rearranged
TCR genes of known specificity revealed a stringent re-
quirement for peptide recognition during the positive se-
lection process (13–16). Affinity measurements of TCR-
peptide–MHC interaction indicated that peptide–MHC
complexes capable of positive selection were of low affinity
for the TCR, whereas high affinity ones were deleting
ligands (17). More recently, natural self-peptides, extracted
from MHC class I groove and capable of driving positive
selection, were identified (18, 19). It was shown that differ-
ent peptides could select thymocytes expressing different
TCRs, suggesting that weak but specific interactions with
self-peptide–MHC complexes promote positive selection
of CD8
 
1
 
 T cells. Hence, a particular TCR could be se-
lected by different peptides.
Peptide involvement in positive selection of CD4
 
1
 
 T
cells was addressed using genetically engineered mice de-
signed to express MHC class II molecules complexed to a
single peptide. In mice lacking the MHC-encoded H-2M
molecule and involved in the removal of the class II–associ-
ated invariant chain peptide (CLIP)
 
1
 
 during the MHC class
II maturation process (20–23), almost all MHC class II
 
1
 
Abbreviations used in this paper:
 
 CLIP, class II–associated invariant chain
peptide; Tg, transgenic mice.
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molecules are occupied with the CLIP peptide (24). Trans-
genic mice (Tg) for the I-A
 
b
 
 chain connected to the
E
 
a
 
52-68 peptide (25, 26) backcrossed to MHC class II–
and invariant chain–deficient animals express the single
E
 
a
 
52-68 peptide–I-A
 
b
 
 complex. Studies conducted with
these two types of Tg suggested that a large and diverse
repertoire of CD4
 
1
 
 T cells is selected (22–27). Staining
with anti-V
 
b
 
 and -V
 
a
 
 antibodies showed that a close to
normal spectrum of V
 
b
 
 and V
 
a
 
 was used by mature CD4
 
1
 
T cells. Sequencing studies in the H-2M
 
2
 
/
 
2
 
 model, from
two V
 
b
 
s and one V
 
a
 
, confirmed the polyclonality (24). Fi-
nally, positively selected cells were capable of responding to
immunization with several peptide antigens (22–24, 27).
In the E
 
a
 
52-68–I-A
 
b
 
 model, Fukui et al. (26) have shown
that the level of expression of this complex in the thymus
affects the CD4
 
1
 
 T cell selection dramatically. Transgenic
lines with low expression of E
 
a
 
52-68–I-A
 
b
 
 complexes pos-
itively select CD4
 
1
 
 T cells, whereas such cells are elimi-
nated in the thymus of another line with high expression
(26). Furthermore, two thirds of the selected CD4
 
1
 
 T cells
react with the syngeneic cells that express the same MHC
class II molecules complexed to the natural set of self-pep-
tides (25). In wild-type mice, such lymphocytes are elimi-
nated by negative selection on bone marrow–derived cells
expressing wild-type class II molecules in the thymus (23,
24). These results indicate that the Tg repertoire of CD4
 
1
 
T cells is different from the wild type. Furthermore, it was
shown using mice expressing various transgenic TCRs
(which are positively selected in mice expressing wild-type
class II molecules) that these TCRs are not selected in the
CLIP mice or the E
 
a
 
52-68–I-A
 
b
 
 Tg (22–24). These obser-
vations imply that the selecting peptide influences, to some
extent, the emerging repertoire. However, the diversity of
the repertoire selected by a single peptide–MHC class II
complex has not been quantitated so far. In addition, the
available evidence does not rule out that a few positively
selected specific TCR rearrangements have not yet been
detected over a polyclonal background.
These studies were designed to quantitate the number of
positively selected T cells. We have analyzed the 
 
a
 
 and 
 
b
 
 T
cell repertoire of CD4
 
1
 
 T lymphocytes selected by the
E
 
a
 
52-68–I-A
 
b
 
 complex extensively. We show that CD4
 
1
 
CD8
 
2
 
NK1.1
 
2
 
HSA
 
2
 
 thymocytes selected on this complex
bear TCRs that include all V
 
b
 
s and 10 V
 
a
 
s tested. The J
 
b
 
usage and CDR3 length distribution of V
 
b
 
 and V
 
a
 
 chain
rearrangements are indistinguishable from the repertoire of
CD4
 
1
 
CD8
 
2
 
NK1.1
 
2
 
HSA
 
2
 
 thymocytes from normal C57Bl/6
mice. Extensive sequencing of particular V
 
b
 
–J
 
b
 
 combina-
tions with the same CDR3 length enabled us to calculate
that a minimum of 10
 
5
 
 different V
 
b
 
 rearrangements are se-
lected by the single peptide–MHC class II complex. Care-
ful analysis of these sequences revealed some differences in
the CDR3 amino acid composition of T cells selected by
the single peptide–MHC complex or by wild-type MHC
class II molecules. Altogether, our results provide a lower
limit on the size of the selected CD4
 
1
 
 T cell repertoire in
vivo
 
 
 
and indicate that part of the repertoire bears the im-
print of the selecting peptide.
 
Materials and Methods
 
Animals.
 
Mice used in this study have been described else-
where (26) and were bred in the animal facility at the Medical In-
stitute of Bioregulation. In brief, Tg were produced by injection
of DNA encoding the 
 
b
 
 chain of I-A
 
b
 
 covalently linked to the
peptide derived from MHC class II E
 
a
 
 (E
 
a
 
52-68) into fertilized
eggs of I-A
 
b
 
b
 
 gene knockout (I-A
 
2/2
 
) mice carrying H-2
 
b
 
 haplo-
type (28). To avoid peptide replacement, Tg were backcrossed
with mice deficient for the invariant chain (Ii
 
2/2
 
; reference 29).
The B2L mice that express 
 
z
 
10% of the level of I-A
 
b
 
 found in
C57Bl/6 animals were chosen for all studies.
 
Purification of CD4
 
1
 
 T Cells.
 
Thymocytes were prepared from
6-wk-old mice and counted. CD4
 
1
 
CD8
 
2
 
NK1.1
 
2
 
HSA
 
2
 
 T cells
were prepared using depletion and cell sorting as previously de-
scribed (26). In brief, thymocytes were incubated with anti-CD8
and anti-HSA (J11D) monoclonal antibodies and killed by addi-
tion of rabbit complement. Remaining living cells were stained
with anti-CD4-PE, anti-CD8-FITC, and anti-NK1.1-FITC (Phar-
Mingen, San Diego, CA). CD4
 
1
 
CD8
 
2
 
NK1.1
 
2
 
HSA
 
2
 
 T cells were
analyzed and sorted on an Epics cell sorter (Coulter Corp., Mi-
ami, FL). For Immunoscope analysis of the T cell receptor reper-
toire, cells were washed with PBS and immediately frozen down
into liquid nitrogen until further manipulation.
 
mRNA Extraction and cDNA Synthesis.
 
Poly(A)
 
1
 
 mRNA from
CD4
 
1
 
CD8
 
2
 
NK1.1
 
2
 
HSA
 
2
 
 thymocytes was extracted (Quick
mRNA Micro Prep Kit; Pharmacia, Piscataway, NJ). In brief,
cells were lysed in guanidium thiocyanate and mRNA samples
were purified by affinity chromatography on oligo-d(T) cellulose.
After ethanol precipitation, mRNAs were reverse transcribed
into cDNA using a cDNA synthesis kit (Boehringer Mannheim
GmbH, Mannheim, Germany). RNA were denaturated at 70
 
8
 
C
for 10 min and then incubated with random primers (5 
 
m
 
M),
dNTP (1 mM), Rnasin (40 U; Promega, Madison, WI) and 2 U
of reverse transcriptase from avian myeloblastosis virus (Boehringer
Mannheim GmbH) at 43
 
8
 
C for 1 h, followed by an incubation at
53
 
8
 
C for 10 min.
 
Immunoscope Analysis of V
 
b and Va Repertoires. PCR was carried
out in 50 ml on 1/50 of the cDNA with 2 U of Taq polymerase
(Goldstar, Eurogentec, Seraing, Belgium) in the buffer provided
by the supplier. Each Vb mRNA was amplified using one of a set
of 23 Vb-specific sense primers and an antisense primer designed
to hybridize in the Cb gene (30). Similarly, Va mRNAs coding
for Va 1, 2, 3, 4, 5, 6, 8, 10, 11, 17, 18, and 19 were amplified
with Va-specific sense primers and an antisense primer from the
Ca region (31).
Each amplified product was then used as a template for an
elongation reaction with oligonucleotides labeled with a fluores-
cent tag (runoff reactions). The fluorescent runoff products, cor-
responding to the elongation of individual Vb or Va PCR prod-
ucts with various CDR3 sizes, were loaded on polyacrylamide
gels and subjected to electrophoresis in an automated DNA se-
quencer. CDR3 size distribution and signal intensities were then
analyzed with the Immunoscope software (30, 32, 33). The pat-
terns observed from unprimed lymph node cells or splenocytes
usually contain six to eight size peaks each spaced by three nucle-
otides, corresponding to the lengths of in-frame transcripts. The
area of each size peak is proportional to the quantity of the TCR
transcripts of the corresponding CDR3 length in the sample. It
should be noted that each peak corresponding to a given CDR3
length is likely to contain multiple distinct sequences. Increase in
the height and area of a size peak signals clonal expansion, occur-
ring against polyclonal background. The fluorescent Cb (or Ca)
primers used in the runoff reactions reveal all Vb-Jb (Va-Ja)1873 Gapin et al.
rearrangements. Runoff reactions using specific fluorescent Jb
primers reveal the CDR3 length distributions from particular V-J
combinations. In brief, 2 ml of each PCR product was subjected
to three to five cycles of elongation with dye labeled specific
primer (0.1 mM) in a final volume of 10 ml, containing 0.2 mM
dNTP, 3 mM MgCl2, and 0.2 U of Taq polymerase (Promega) in
buffer (Promega). The elongation starts with 1 min at 948C, fol-
lowed by three to five cycles each consisting of 45 s at 948C, 45 s
at 608C, 45 s at 728C, and ending with a step at 728C for 3 min.
Each runoff product was then diluted vol/vol in 30 mM EDTA-
formamide solution. This mix was heat-denatured during 10 min
at 808C and 2 ml aliquot was loaded on a 6% (or 4.25%) polyacryl-
amide 8 M urea gel. Gel electrophoreses were performed on a
DNA sequencer (373A or 377; PE Applied Biosystems, Foster
City, CA). Peak size and fluorescent intensity were determined
with the Immunoscope software (32, 34–36). Because the tech-
nique is semiquantitative, we could evaluate the relative fre-
quency of Jb usage for a given Vb population, as described in ref-
erence 37. The ratio of the area of the peak generated with a
given Jb primer to the areas of all the Jb primers was calculated as
a measure of the relative frequency of Jb usage in the Vb1 cell
population under study.
Sequencing of Particular Vb-Jb Rearrangements with a Given
Length. Two PCR reactions were performed using specific
Vb11-Jb1.1 or Vb12-Jb1.1 primers in 50 ml on 1/50 of the
cDNA with 2 U of Taq polymerase (Goldstar, Eurogentec) in the
supplier’s buffer. The elongation starts with 1 min at 948C, fol-
lowed by 40 cycles each consisting of 45 s at 948C, 45 s at 608C,
45 s at 728C, and ending with a step at 728C for 3 min. The PCR
product was ethanol precipitated and resuspended in 10 ml form-
amide containing 0.05% bromophenol blue and 0.05% xylene cy-
anol. This mix was heat denatured for 10 min at 808C and then
loaded on a 8% polyacrylamide/7 M urea gel. After migration,
PCR products were visualized by a silver coloration (DNA Silver
Staining System; Promega) following manufacturer’s instructions.
We usually obtained six to eight bands each spaced by three nu-
cleotides, corresponding to in-frame transcripts of the V-J combi-
nations. Bands of interest, corresponding to a given CDR3
length, were cut from the gel and disrupted in 40 ml of water. A
second PCR was carried out using the same primers on 2 ml of
the isolated PCR product with 2 U of Taq polymerase (Goldstar,
Eurogentec) in the supplier buffer for 20 cycles. Further purifica-
tion was realized on a 15% nondenaturating acrylamide gel in
TBE. Staining of this gel was obtained with a 30 min bath in a
0.5 mg/ml ethidium bromide solution in TBE (Tris-borate-
EDTA). PCR product was electroeluted in TBE and purity of
the sample was estimated by a runoff reaction with the fluorescent
Jb primer. We usually obtained 90–95% purity of the final prod-
uct with the expected size. PCR products were then cloned in
pCRÒ2.1 vector from the TA cloning kit (Invitrogen, Carlsbad,
CA). 10–20 ng of DNA were ligated with an equimolar concen-
tration of the vector. The ligation was carried out in 10 ml with 4 U
of T4 DNA ligase during 12 h at 148C, following the manufac-
turer’s instructions. Competent INVaF9 bacteria (Invitrogen)
were then transformed by heat shock at 428C for 30 s and plated
on Luria-Bertani medium containing 50 mg/ml ampicillin and 60
mg/ml X-Gal (ICN Biomedicals Inc., Aurora, OH).
For the purpose of sequencing, PCR was carried out directly
on LacZ2 colonies in a final volume of 30 ml using universal
primers RP and M13(-40) designed to hybridize on each side of
the polylinker where the Vb-Jb PCR product was cloned. 5 ml
of this PCR product was treated during 40 min at 378C with 1 U
of shrimp alkaline phosphatase (Nycomed Amersham, Bucking-
hamshire, UK) and 10 U of exonuclease (Nycomed Amersham)
in a final volume of 10 ml. Both enzymes were heat denatured at
808C for 20 min. Sequencing reactions were carried out directly
on these products using M13(-20) primer and the ABI PRISMÔ
Dye Terminator Cycle Sequencing Ready Reaction Kit follow-
ing the manufacturer’s instructions (PE Applied Biosystems). Re-
action products were loaded on a 4.25% polyacrylamide 8 M urea
gel. Gel electrophoreses were performed on a DNA sequencer
(377; PE Applied Biosystems), and CDR3 region corresponding
sequences were extracted and analyzed using software designed
for this purpose (Casrouge, A., E. Beaudoing, J.P. Levraud, L.
Gapin, N. Garguier, D. Gautheret, J.M. Claverie, J. Kanellopoulos,
P. Kourilisky, manuscript in preparation).
Results
CDR3 Size Distribution of TCR-a/b Repertoire from
CD41CD82NK1.12HSA2 Thymocytes Positively Selected by a
Single Peptide–MHC Complex. Single positive CD4 thymo-
cytes were purified from the thymus of B2L, which are trans-
genic for a single peptide–MHC class II complex (26). The
repertoire analysis did not include CD41CD82 NK1.11 cells,
which were eliminated by specific lysis with antibodies and
complement, because it is known that such cells are selected
by nonclassical MHC class I molecules such as CD1 (38).
mRNA from 3–4 3 105 CD41CD82NK1.12HSA2
thymocytes was extracted and reverse transcribed into
cDNA. 23 Vb- and 12 Va-specific PCR reactions were
then carried out. The product of each PCR was visualized
by performing a runoff extension with internal Cb- (or
Ca-) specific fluorescent primer. Such primers enable
elongation through the CDR3 region of each amplified
product, and therefore reveal peaks of different sizes for all
V-J combinations after separation on a sequencing gel. Pre-
vious studies from our laboratory, using unstimulated
mouse splenocytes, have shown that, in all functional rear-
ranged Vb or Va segments, the CDR3 size patterns display
six to eight peaks spaced by three nucleotides. These peaks
are distributed in Gaussian-like patterns that are characteris-
tic of polyclonal T lymphocytes (34). The repertoire analy-
sis performed on single positive CD4 cells selected on the
Ea52-68 peptide–I-Ab complexes is shown in Fig. 1. 22
out of the 23 Vb genes were amplified (Fig. 1 A). Amplifi-
cation of Vb6 gene failed for technical reasons. All Va
genes tested were amplified (Fig. 1 B). The size distribution
of CDR3 from each Va or Vb family gives a set of about
seven peaks, each spaced by three nucleotides and corre-
sponding to in-frame transcripts. For Vb17 and Vb19
genes that are pseudogenes in C57Bl/6 mice (39–41), in-
frame transcripts are difficult to detect above the back-
ground of out-of-frame transcripts. To detect more subtle
modifications of the Vb repertoire, we performed runoff
reactions with 12 fluorescent primers that recognize indi-
vidual Jb segments for the Vb4, Vb8.2, Vb10, Vb11,
Vb12, and Vb14 families. The CDR3 distribution of spe-
cific Vb-Jb rearrangements was then obtained for the six
different Vbs of two individual Tg. Our results clearly
show that for each Vb, all Jbs are used. Furthermore, the1874 Single Peptide–MHC Complex Selects a Skewed T Cell Repertoire
CDR3 distribution of these rearrangements has a Gaussian-
like profile (Vb11 in Fig. 2 B; otherwise, data not shown).
We have observed previously that in every situation char-
acterized by the expansion of specific clone(s) (35, 36, 42)
or the presence of oligoclonal populations (43), the analysis
with the Immunoscope technique always revealed perturba-
tions of the CDR3 size profile. Therefore, the Gaussian-like
profile obtained for CD41CD82NK1.12HSA2 thymocytes
selected by a single peptide–MHC class II complex indi-
cates that the repertoire is polyclonal.
Comparison of the a/b Repertoire of CD41CD82NK1.12
HSA2 Thymocytes from Transgenic Mice for the Ea52-68 Pep-
tide–I-Ab Complex and C57Bl/6 Mice. Repertoire analysis
was performed on CD41CD82NK1.12HSA2 thymocytes
from C57Bl/6 mice as described in previous sections.
CDR3 size distributions obtained with Cb or Ca primers
for each Vb or Va chain were compared with those from
cells selected by the single peptide–MHC class II complex
(Fig. 2 A and data not shown). Our results show that for all
Vb and Va, the profiles are superimposable. On Fig. 2 A
are shown representative results for Vb4, Vb8.2, Vb10,
Vb11, Vb12, and Vb14.
A more detailed analysis of Vb-Jb rearrangements was
performed for Vb4, Vb8.2, Vb10, Vb11, Vb12, and
Vb14. Representative results obtained with Vb11 are
shown on Fig. 2 B. The repertoires were superimposable
and no significant modification was found with any Jb
primer.
Similar Usage of Jb Gene Segments by TCR from CD41
CD82NK1.12HSA2 Thymocytes Selected in Wild-type Mice
or in Transgenic Animals Expressing a Single Peptide–MHC Class
II Complex. The relative Jb usage in the Vb11, Vb12,
and Vb14 T cell population measured from one individual
mouse of each strain (B2L and C57Bl/6) is shown in Fig. 3.
The ratio of the area of the peaks generated with a given Jb
primer to the areas of all the Jb primers was calculated as a
measure of the relative frequency of Jb usage. This analysis
does not reveal any significant evidence of selection for a
particular Jb and shows that the Jb2 segments are used
more frequently than the Jb1 segments as previously de-
Figure 1. Profiles of the fluorescent Vb-Cb (A) and Va-Ca (B) runoff products obtained with CD41CD82NK1.12HSA2 thymocytes from single
chain peptide–MHC class II complex Tg. Results are representative of two mice tested independently. The intensity of fluorescence is represented in ar-
bitrary units as a function of the size of the single DNA fragments.1875 Gapin et al.
scribed in the normal repertoire (44). Altogether, these re-
sults strongly suggest that the T cell repertoire selected by a
single peptide–MHC complex is indistinguishable in terms
of Vb, Jb, and Va usage and CDR3 size distribution from
the one selected by multiple peptide–MHC class II com-
plexes.
Sequence Complexity in a Given Vb-Jb Rearrangement with
a Defined CDR3 Length. Each peak corresponding to a
given CDR3 length contains multiple distinct sequences.
To evaluate the sequence complexity of the repertoire
from CD41 T cells selected by the Ea52-68 peptide–I-Ab
complex, we have chosen to focus arbitrarily on two par-
ticular rearrangements with a given CDR3 length: Vb11-
Jb1.1 with a CDR3 length of six amino acids and Vb12-
Jb1.1 with a CDR3 length of eight amino acids. These
two Vbs are well selected in B2L mice, but reasonably
abundant in both B2L and C57Bl/6 animals so that the an-
ticipated complexity would be more amenable to our anal-
ysis. The same consideration guided the choice of the
CDR3 lengths.
Each peak corresponding to these rearrangements was
isolated and purified. The sequence mixture contained in
these peaks was cloned and every positive clone was se-
quenced. More than 700 sequences were collected. We
found that, in the two rearrangements tested, the number
of different sequences collected from each sample is in the
same range of magnitude, with a mean of 30 different se-
quences in the Vb11-Jb1.1 peak with a CDR3 length of
six amino acids and a mean of 70 different sequences in the
Vb12-Jb1.1 peak with a CDR3 length of eight amino ac-
ids (Table 1). Hence, sequence diversity contained in a
given Vb rearrangement with a particular length is the
same between wild-type mice and Tg. Since we could esti-
mate the number of different sequences contained in a sin-
gle peak, we calculated the minimal number of rearrange-
ments positively selected by the Ea52-68–I-Ab complex.
The Vb11-Jb1.1 combination with a CDR3 length of six
amino acids represents 13% of the rearrangements using the
Vb11 and Jb1.1 gene segments. The Jb1.1 is used in 5% of
the rearrangements involving the Vb11 gene segment.
Staining with specific monoclonal antibody shows that 5%
of the CD41CD82NK1.12HSA2 thymocytes from the Tg
bear the Vb11 chain (26). We then estimated that a mini-
mum of 105 TCR-b rearrangements (30 3 7.7 [to correct
for the CDR3 length] 3 20 [to correct for all the Jbs] 3 20
[to correct for all the Vbs]) are selected by the peptide–
Figure 2. Comparison of the fluorescent runoff products profiles obtained from CD41 mature thymocytes from single chain peptide–MHC class II
complex Tg (solid lines) and C57Bl/6 mice (dotted lines). Runoff extensions were performed for Vb4, Vb8.2, Vb10, Vb11, Vb12, and Vb14 with internal
Cb-specific fluorescent primer (A) and for Vb11 with 12 Jb-specific primers (B). The intensity of fluorescence is represented in arbitrary units as a func-
tion of CDR3 size in amino acids. Two mice were tested independently for each repertoire. Results were superimposable for the two mice tested in each
combination.1876 Single Peptide–MHC Complex Selects a Skewed T Cell Repertoire
MHC class II complex. The same calculation was applied
for the Vb12-Jb1.1 rearrangement and a total of 7 3 104
TCR-b rearrangements were found.
Recurrent Sequences of the Vb Chain CDR3 Region from CD41
CD82NK1.12HSA2 Thymocytes of Wild-type Mice or Trans-
genic Animals Expressing Ea52-68–I-Ab Complex. Among the
700 sequences collected, we found some recurrent se-
quences between animals. The results obtained with the
Vb11-Jb1.1 and Vb12-Jb1.1 rearrangements are shown in
Fig. 4. For the Vb11-Jb1.1 rearrangement, only one recur-
rent amino acid sequence was found in all animals. This
CDR3 is generated by the same nucleotide sequence and is
encoded by the germline segments without trimming or N
nucleotide addition (data not shown). For the Vb12-Jb1.1,
four recurrent sequences were found between the C57Bl/6
mouse and one Tg, and seven between the same C57Bl/6
mouse and another Tg. Between the two Tg, nine amino
acid sequences of the CDR3 were recurrent. Among these,
two CDR3 amino acid sequences were common to all ani-
mals tested: SLGANTEV and SLTANTEV (see Fig. 4).
The SLGANTEV sequence was found one time in the
C57Bl/6 animal, four times in one Tg, and two times in
the other Tg tested (Table 2). Nucleotide sequence analysis
of these rearrangements revealed that in each mouse, the
sequence was generated differently by the recombination
machinery (see Table 2). From the C57Bl/6 mice, the cod-
ing sequence was obtained with the trimming of three nu-
cleotides from the Vb12 germline segment, the usage of
four nucleotides from the Db1 segment, 1 P nucleotide ad-
dition between the D and the J segments, and the germline
sequence of the Jb1.1 gene segment. This specific rear-
rangement was never found in the two Tg tested. In these
two animals, recombination events (Vb trimming, Db us-
age, N nucleotide addition) were different (see Table 2).
However, one should notice that recurrent nucleotide se-
quences were also found between Tg. Comparable conclu-
sions were reached when we analyzed the nucleotide se-
quences encoding the recurrent SLTANTEV (Table 2).
Altogether, these results strongly suggest that these two
CDR3 regions are not preferentially generated by the re-
combination machinery, but are positively selected at the
amino acid level.
Comparison of the Amino Acid Frequency at Different Posi-
tions in the CDR3 Region of Vb-Jb Rearrangements from
CD41CD82NK1.12HSA2 Thymocytes of Wild-type Mice or
Transgenic Animals Expressing Ea52-68–I-Ab Complex. We
compared the amino acid usage in the CDR3 region of the
two sequenced rearrangements Vb11-Jb1.1 (CDR3 length
of six amino acids) and Vb12-Jb1.1 (CDR3 length of eight
amino acids) of the CD41CD82NK1.12HSA2 thymocytes
from Tg and wild-type mice. No difference was detected
between mice when the individual percentage of amino ac-
ids in the CDR3 was plotted (data not shown). However,
interesting differences became apparent when we plotted
the frequency of individual amino acids at each position in
the CDR3 loop (Figs. 5 and 6). Frequencies were calcu-
Figure 3. Jb usage of Vb11, Vb12, and Vb14 of CD41CD82
NK1.12HSA2 thymocytes from B2L Tg (black bars) and C57Bl/6 mice
(white bars). In the abscissa are represented all members of the Jb family. In
the ordinate is plotted the relative frequency of Jb usage, calculated as de-
scribed in Materials and Methods. The results were generated from one
mouse of each strain.
Table 1. Sequence Complexity in a Given Vb-Jb Rearrangement 
with a Defined CDR3 Length
Mice
Total No.
of sequences
No. of different
sequences
No. of unique
sequences
Vb11-Jb1.1 CDR3 length: six amino acids
C57Bl/6 159 34 12
C57Bl/6 180 27 0
Tg 33 25 18
Tg 58 34 21
Vb12-Jb1.1 CDR3 length: eight amino acids
C57Bl/6 112 73 44
Tg 95 81 68
Tg 81 60 501877 Gapin et al.
lated with nonredundant sequences in order to eliminate
bias due to overrepresented sequences. Positions 2 and 3
for the Vb11-Jb1.1 rearrangement and 2, 3, and 4 for the
Vb12-Jb1.1 rearrangement are more variable due to N or
P nucleotide additions and reading frame usage of the Db
gene segment. One can notice that for each variable posi-
tion, a limited number of amino acid residues are found
and that they are similar in all mice. Furthermore, the per-
centage of amino acid residues found at each variable posi-
tion (2, 3, and 4) is strikingly similar between C57Bl/6
mice and Tg. However, for the Vb11-Jb1.1 rearrange-
ment, it appears that at position three of the CDR3 from
Tg, there is an increase in the frequency of the asparagine
residue as compared with wild-type mice (24 versus 8%; see
Fig 5). Similar skewing is also found with the Vb12-Jb1.1
rearrangement. When comparing amino acid frequency
between wild-type mice and Tg, we found an increase in
leucine at position 2, threonine and glutamine at position
3, and glycine at position 4 of the CDR3 loop of transgenic
animals (Fig. 6). In contrast, in C57Bl/6 mice, glycine is
preferentially found in position 3 of the CDR3. Analysis of
nucleotide sequences encoding glycine or glutamine at this
position shows that both amino acids are encoded by the
Db1.1 gene segment in all CDR3s. Glycine can be en-
coded by all three Db1.1 reading frames. There are six pos-
sibilities to code for glycine. In Tg and wild-type mice, all
encoding possibilities are used (Fig. 7), indicating that there
is no bias due to the recombination machinery between
these mice. Strikingly, in Tg animals, glutamine is found
more frequently at this position (Fig. 6) even though this
residue is only encoded by frame 2 of the Db1.1 gene seg-
ment. Altogether these results suggest that this residue has
been selected for at the amino acid level. Furthermore, the
preferential usage of the Db1.1 frame 2 in the transgenic
animals should favor the appearance of a glycine residue at
position 4. This increase in glycine frequency at position 4
is observed in transgenic animals and not in C57Bl/6 (Fig.
6). These differences in amino acid usage at different posi-
tions of the b chain CDR3 junctions reveal the imprint of
the Ea52-68 peptide–I-Ab complex on the selected T cell
repertoire.
Figure 4. Recurrent sequences of the Vb chain CDR3 region from
CD41CD82NK1.12HSA2 thymocytes of wild-type mice or transgenic
animals expressing Ea52-68–I-Ab complex are displayed. Recurrent se-
quences between individual animals are shown and the sequences com-
mon to all animals are in bold.
Table 2. Nucleotide and Amino Acid Translated Sequences of Vb12-Jb1.1 Recurrent Rearrangements with a CDR3 Length of Eight
Amino Acids
Germline Vb12 N/P Db1 N/P Jb1.1
TGT GCC AGC AGT TTA GC GGG ACA GGG GGC CA AAC ACA GAA GTC TTC
C57Bl/6
13* TGT GCC AGC AGT TT GGG A G CA AAC ACA GAA GTC TTC CASSLGANTEV
Tg1
13 TGT GCC AGC AGT TTA G GGG CA AAC ACA GAA GTC TTC CASSLGANTEV
33 TGT GCC AGC AGT TTA G G GGC C AAC ACA GAA GTC TTC CASSLGANTEV
Tg2
23 TGT GCC AGC AGT TTA G GGG CA AAC ACA GAA GTC TTC CASSLGANTEV
C57Bl/6
13 TGT GCC AGC AGT TTA ACA G CA AAC ACA GAA GTC TTC CASSLTANTEV
Tg1
23 TGT GCC AGC AGT TT G ACA G CA AAC ACA GAA GTC TTC CASSLTANTEV
Tg2
13 TGT GCC AGC AGT TTA ACA G CA AAC ACA GAA GTC TTC CASSLTANTEV
13 TGT GCC AGC AGT TTA AC GG CA AAC ACA GAA GTC TTC CASSLTANTEV
33 TGT GCC AGC AGT TT G ACA G CA AAC ACA GAA GTC TTC CASSLTANTEV
*No. of times this sequence was found in the animal.1878 Single Peptide–MHC Complex Selects a Skewed T Cell Repertoire
Discussion
At Least 105 Distinct TCR-b Rearrangements Are Selected
by the Single MHC–Peptide Complex Displayed in B2L
Mice. The involvement of peptides presented by MHC
molecules in the process of thymic positive selection of T
cells has been investigated in vivo (25, 26, 45–49) and in
vitro (11, 12, 14, 50). Recent studies (23, 24, 27) have
shown that positive selection is a promiscuous process en-
abling the selection of many different TCR rearrangements
by a single peptide–MHC class II complex, but their diver-
sity has not been quantified so far. Here, we have estimated
the number of TCR rearrangements in mature thymocytes
positively selected in Tg B2L mice (26) designed to express
a single peptide–MHC class II complex (the Ea52-68 pep-
tide hooked to I-Ab). Their Ii2/2 genetic background guar-
antees that the physiological route of peptide loading is
blocked (29). Similar mice, engineered by Ignatowicz et al.
(25), have been shown (contrary to H-2M2/2 mice) to
present no other detectable self-peptides (22).
B2L mice express low levels of the Ea52-68–I-Ab com-
plex in their thymus and on z5–10% of their splenocytes
and positively select a number of CD41 T cells, which is
z20–50% of C57Bl/6 (26). We analyzed RNA from
CD41CD82NK1.12HSA2 T cells isolated from C57Bl/6
and from B2L mice by a PCR-based approach designed to
determine the CDR3 lengths of the b and a chains. All
Vb-Jb combinations were used to visualize an overall pic-
ture of the b repertoire based upon some 2,000 measure-
ments. Given the larger number of Ja segments, the a rep-
ertoire was not totally analyzed but sampled with 12 Va
families. The normal mouse repertoire is characterized
by bell-shaped, Gaussian-like, CDR3 length distributions
(30). Distortions are observed upon antigenic stimulations
that cause sufficient clonal expansion (34–36, 42). Oligo-
clonal distributions in pathological infiltrates are easily de-
picted (51–55). B2L CD41 T cell profiles were remarkably
Gaussian-like and quasisuperimposable to wild type. The
Jb usage for Vb11, Vb12, and Vb14 closely matched that
observed in C57Bl/6. Moreover, B2L and C57Bl/6 dis-
played overlapping CDR3 size distributions, even though
the average CDR3 length is different for distinct Vb seg-
ments (30). No spikes suggesting clonal or oligoclonal ex-
pansions were detected. Therefore, the single MHC–pep-
Figure 5. Amino acid frequency at the different positions in the CDR3 region of Vb11-Jb1.1 (length: six amino acids) rearrangements from
CD41CD82NK1.12HSA2 thymocytes. Top, the results obtained from two independent C57Bl/6 mice; bottom, the results obtained from two indepen-
dent Tg. Amino acid frequencies were calculated with nonredundant sequences to avoid skewing due to overrepresented sequences (34 and 27 sequences
and 25 and 34 sequences were used for C57Bl/6 mice and Tg, respectively).1879 Gapin et al.
Figure 7. Db reading frame
usage coding for glycine or
glutamine residues at position 3
of eight amino acids–long
CDR3 region of Vb12-Jb1.1 re-
arrangements. (A) The nucle-
otide sequences (bold) encoding a
glycine residue at position 3 of
the CDR3 region from C57Bl/6
(top) and Tg (bottom) thymocytes.
(B) The nucleotide sequences
(bold) encoding a glutamine resi-
due at position 3 of the CDR3
region from C57Bl/6 (top) and
Tg (bottom) thymocytes. All the
sequences were aligned follow-
ing the Db reading frame usage,
regardless of the Vb, Jb gene
segment trimming, and N addi-
tion.
Figure 6. Amino acid frequency at the different positions in the CDR3 region of Vb12-Jb1.1 (length: eight amino acids) rearrangements from
CD41CD82NK1.12HSA2 thymocytes. Top, the results obtained from one C57Bl/6 mouse; bottom, the percentage of usage obtained from two indepen-
dent Tg. Amino acid frequencies were calculated with nonredundant sequences to avoid skewing due to overrepresented sequences (73 sequences and 81
and 60 sequences were used for C57Bl/6 mice and Tg, respectively).1880 Single Peptide–MHC Complex Selects a Skewed T Cell Repertoire
tide complex in B2L mice did not preferentially select a
small number of clones over an otherwise polyclonal back-
ground.
We cloned and sequenced from B2L and C57Bl/6 mice
the Vb11-Jb1.1 and Vb12-Jb1.1 size peaks with CDR3
lengths of six and eight amino acids, respectively. We could
thus (Table 1) establish that the Tg and wild-type mice
repertoires both include a minimum of 105 b rearrange-
ments, suggesting that the Tg repertoire is about as diverse
as the wild-type one. In addition, the number of distinct a
chains capable of pairing with a given rearranged b chain
has not been determined in physiological conditions. The
work of Sant’Angelo et al. (56) showed that 20–30 differ-
ent a chains can associate with a unique transgenic rear-
ranged b chain. If this figure can be extrapolated to physio-
logical situations, the number of different TCRs would be
much higher than 105, leaving open the possibility that each
positively selected CD41 thymocyte displays a unique TCR.
The Transgenic Repertoire Is Skewed in at least Two Ways
with Respect to the Wild-type Repertoire. The above data show
that the preferential selection of certain Vbs, observed in
B2L mice by Fukui et al. (26), is not reflected in a few
clonal expansions but in a larger number of rearrangements
as revealed by the Gaussian distributions. This suggests that
the Ea52-68 peptide prevents proper association with the
subset of Vb segments that are not efficiently selected, that
it is instrumental in binding those Vb segments that are se-
lected (57), or both. The amino acid usage, compiled in
Figs. 5 and 6, shows a second level of skewing now involv-
ing the CDR3 regions. We are confident that these differ-
ences in the amino acid composition at some CDR3 posi-
tions are significant. First, in conserved positions we find
no variation of the amino acid usage between Tg and wild-
type mice. Second, we evaluated the percentage of se-
quencing errors at conserved positions such as the C922,
A932,S942-encoded positions of the CDR3. The figure of
0.3% at each position cannot explain the results. Third,
amino acid usage calculations were done with nonredun-
dant sequences in order to avoid skewing due to overrepre-
sentation. Fourth, such percentage variations are consistent
from one mouse to another of the same lineage (Tg versus
wild-type mice).
The elegant studies by Sant’Angelo et al. (56) have pro-
vided strong evidence for an imprint of the peptide in the
process of positive selection. Here we had no direct way to
evaluate the respective impact of positive and negative se-
lection in shaping the B2L repertoire of CD41 thymocytes.
However, the recurrent b chain rearrangements that we
have observed (Fig. 4) are likely to reflect positive selection
events, since they could hardly be the result of chance, or
of a negative process that would delete all sequences but
these ones. Remarkably, among these recurrent b chains,
two were found in both B2L and C57Bl/6. They were en-
coded by nonidentical nucleotide sequences and generated
by distinct junctional events (Figs. 4 and 7), implying that
they were selected at the amino acid level in a positive
fashion. It is worth noting that C57Bl/6 mice do not ex-
press nor present the Ea52-68 peptide (58, 59). Therefore,
in this case, the event that positively selected the b chain
involved no peptide or self-peptides sharing amino acid
residues with Ea52-68, or was mediated by the a chain.
In the peripheral response to several defined antigens,
one or a few specific CDR3 sequences, in given Vb-Jb
and/or Va-Ja combinations, have been found to be highly
reproducible and shared by individual animals. They were
named “public” (35) by analogy with recurrent idiotypes
found in immunoglobulins (60). Whether these public re-
arrangements are selected in the periphery or in the thymus
has not been determined so far. Since, as shown above, at
least some recurrent rearrangements are positively selected
in the thymus, it may be proposed that peripheral public
rearrangements, in general, bear the imprint of thymic pos-
itive selection.
Altogether, our results also show that the impact of a
peptide in positive selection may not be readily detected.
First, our data indicate that the peptide may not be directly
involved in all selection events regarding the b chain since
the a chain may also be involved in the selection process.
This raises the possibility that not all TCR-b rearrange-
ments bear the imprint of the peptide. Second, in order to
detect the latter, we had to focus on a specific Vb-Jb com-
bination with a fixed CDR3 length, whereas Sant’Angelo
et al. studied a chain rearrangements associated with a b
chain that had been fixed by transgenesis (56). This may
explain some apparently conflicting results about peptide
specificity in positive selection.
How is the T Cell Repertoire Shaped in Wild-type Mice?
The physiological relevance of observations made in trans-
genic animals is questionable. Among the few reports on
positive selection in nontransgenic animals (for review see
reference 61), the comparison of positive selection of anti-
ovalbumin TCR in Kb and Kbm8 mutant mice has provided
a clear indication for the involvement of presented peptides
(45). The single peptide–MHC complex of B2L mice
makes up z10% of physiological complexes in the thymic
cortex of B10-A(5R) mice. According to Grubin et al. (22),
rare peptides (expressed, in their case, in the H-2M–defi-
cient background) appear functional in positive selection
whether the diversity of the T cell repertoire is built up
only by the most abundant self-peptides like Ea52-68, or
by rarer self-peptides as well. In the latter case, it remains to
be determined to which extent the diversity of thymocytes
is increased by rarer peptides in a cumulative fashion. We
are currently performing an extensive repertoire analysis
of B10-A(5R) mice in order to evaluate whether and to
which degree it includes or overlaps with that of B2L
animals.
We would like to thank Drs. Anna Cumano, Mitchell Kronenberg, François Lemonnier, Jean-Pierre
Levraud, and Alfred Singer for discussion and critical review of the manuscript.1881 Gapin et al.
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